Nutritional Repair of Neurons and Amyotrophic Lateral Sclerosis Research Institute (Hong Kong)Introduction

1. Background of Establishment

The global incidence of neurodegenerative diseases is rising sharply. Current medical approaches have yet to identify clear etiologies or develop highly effective therapeutics, imposing a heavy burden on patients, families, and society at large. Since 2009, the Medxin team has conducted extensive clinical research, demonstrating that their approach can suppress—and even reverse—disease progression in patients at early, intermediate, and advanced stages. To integrate global resources and intensify collaborative efforts against these conditions, the team initiated the establishment of this society.

—Core Objective:： Building upon existing achievements, deepen research to clarify the mechanisms of nutritional intervention, its clinical efficacy, and the metabolic pathways of key nutrients, ultimately achieving clinical cures for neurodegenerative diseases—including amyotrophic lateral sclerosis (ALS).

—Key Significance: Offering renewed hope for patient recovery; providing a China-originated solution for research into these diseases; and pioneering a novel integrative pathway that combines traditional Chinese dietary therapy with modern medicine.

Assemble a world-class, multidisciplinary research team and establish deep collaborative exchanges with global scientific institutions to conduct clinical trials of nutritional restoration therapies according to international standards.

Within three years, elucidate the mechanisms underlying nutritional restoration, define metabolic patterns of therapeutic nutrients, and develop highly effective intervention protocols. In the long term, the society aims to become a global hub for research in this field, driving forward medical innovation and progress.